Lawton M, Rutledge W, Kim H, Stapf C, Whitehead K, Li D, Krings T, Terbrugge K, Kondziolka D, Morgan M et al (2015) Brain arteriovenous malformations. Nat Rev Dis Primers 1:15008

Article  Google Scholar 

Gabriel R, Kim H, Sidney S, McCulloch C, Singh V, Johnston S, Ko N, Achrol A, Zaroff J, Young W (2010) Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke 41:21–26

Article  Google Scholar 

Hong T, Yan Y, Li J, Radovanovic I, Ma X, Shao Y, Yu J, Ma Y, Zhang P, Ling F et al (2019) High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain 142:23–34

Article  Google Scholar 

Kawasaki J, Aegerter S, Fevurly R, Mammoto A, Mammoto T, Sahin M, Mably J, Fishman S, Chan J (2014) RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity. J Clin Investig 124:2774–2784

CAS  Article  Google Scholar 

Nikolaev S, Vetiska S, Bonilla X, Boudreau E, Jauhiainen S, Jahromi BR, Khyzha N, DiStefano P, Suutarinen S, Kiehl T et al (2018) Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 378:250–261

CAS  Article  Google Scholar 

Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674

CAS  Article  Google Scholar 

Haunerland N, Spener F (2004) Fatty acid-binding proteins–insights from genetic manipulations. Prog Lipid Res 43:328–349

CAS  Article  Google Scholar 

Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, Bischoff J, Cataltepe S (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23:3865–3873

CAS  Article  Google Scholar 

Furuhashi M, Fucho R, Görgün C, Tuncman G, Cao H, Hotamisligil G (2008) Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Investig 118:2640–2650

CAS  PubMed  PubMed Central  Google Scholar 

Elmasri H, Ghelfi E, Yu C, Traphagen S, Cernadas M, Cao H, Shi G, Plutzky J, Sahin M, Hotamisligil G et al (2012) Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway. Angiogenesis 15:457–468

CAS  Article  Google Scholar 

Wang Y, Chen J, Tang W, Zhang Y, Li X (2017) Rapamycin inhibits the proliferation of endothelial cells in hemangioma by blocking the mTOR-FABP4 pathway. Biomed Pharmacother 85:272–279

CAS  Article  Google Scholar 

Zudaire E, Gambardella L, Kurcz C, Vermeren S (2011) A computational tool for quantitative analysis of vascular networks. PLoS ONE 6:e27385

CAS  Article  Google Scholar 

Berg J, Gallione C, Stenzel T, Johnson D, Allen W, Schwartz C, Jackson C, Porteous M, Marchuk D (1997) The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61:60–67

CAS  Article  Google Scholar 

McAllister K, Grogg K, Johnson D, Gallione C, Baldwin M, Jackson C, Helmbold E, Markel D, McKinnon W, Murrell J (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345–351

CAS  Article  Google Scholar 

Shirley M, Tang H, Gallione C, Baugher J, Frelin L, Cohen B, North P, Marchuk D, Comi A, Pevsner J (2013) Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971–1979

CAS  Article  Google Scholar 

Krithika S, Sumi S (2021) Neurovascular inflammation in the pathogenesis of brain arteriovenous malformations. J Cell Physiol 236:4841–4856

CAS  Article  Google Scholar 

Shoemaker L, McCormick A, Allen B, Chang S (2020) Evidence for endothelial-to-mesenchymal transition in human brain arteriovenous malformations. Clin Transl Med 10:e99

Article  Google Scholar 

Cataltepe S, Arikan M, Liang X, Smith T, Cataltepe O (2015) Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling. Neuropathol Appl Neurobiol 41:646–656

CAS  Article  Google Scholar 

Dormond-Meuwly A, Roulin D, Dufour M, Benoit M, Demartines N, Dormond O (2011) The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitors. Biochem Biophys Res Commun 407:714–719

CAS  Article  Google Scholar 

Manning B, Toker A (2017) AKT/PKB signaling: navigating the network. Cell 169:381–405

CAS  Article  Google Scholar 

Woodcock H, Eley J, Guillotin D, Platé M, Nanthakumar C, Martufi M, Peace S, Joberty G, Poeckel D, Good R et al (2019) The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun 10:6

CAS  Article  Google Scholar 

Pause A, Belsham G, Gingras A, Donzé O, Lin T, Lawrence J, Sonenberg N (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5’-cap function. Nature 371:762–767

CAS  Article  Google Scholar 

Terruzzi I, Pellegatta F, Luzi L (2005) Differential p70S6k and 4E-BP1 regulation by insulin and amino acids in vascular endothelial and smooth muscle cells. Acta Diabetol 42:139–146

CAS  Article  Google Scholar 

Ramanathan A, Schreiber S (2009) Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci USA 106:22229–22232

CAS  Article  Google Scholar 

Kang S, Pacold M, Cervantes C, Lim D, Lou H, Ottina K, Gray N, Turk B, Yaffe M, Sabatini D (2013) mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 341:1236566

Article  Google Scholar 

Gao H, Zhang J, Liu T, Shi W (2011) Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: an in vitro study. Mol Vis 17:3406–3414

CAS  PubMed  PubMed Central  Google Scholar 

Zheng N, Ding X, Jahan R (2014) Low concentration of rapamycin inhibits hemangioma endothelial cell proliferation, migration, and vascular tumor formation in mice. Curr Ther Res Clin Exp 76:99–103

CAS  Article  Google Scholar 

Si Y, Chu H, Zhu W, Xiao T, Shen X, Fu Y, Xu R, Jiang H (2018) Concentration-dependent effects of rapamycin on proliferation, migration and apoptosis of endothelial cells in human venous malformation. Exp Ther Med 16:4595–4601

CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Wu P, Dai J, Zhang T, Bihl J, Wang C, Liu Y, Shi H (2020) Inhibition of mTOR alleviates early brain injury after subarachnoid hemorrhage via relieving excessive mitochondrial fission. Cell Mol Neurobiol 40:629–642

CAS  Article  Google Scholar 

Harjes U, Bridges E, McIntyre A, Fielding B, Harris A (2014) Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells. J Biol Chem 289:23168–23176

CAS  Article  Google Scholar 

Kevil C, Orr A, Langston W, Mickett K, Murphy-Ullrich J, Patel R, Kucik D, Bullard D (2004) Intercellular adhesion molecule-1 (ICAM-1) regulates endothelial cell motility through a nitric oxide-dependent pathway. J Biol Chem 279:19230–19238

CAS  Article  Google Scholar 

Ruiz S, Zhao H, Chandakkar P, Papoin J, Choi H, Nomura-Kitabayashi A, Patel R, Gillen M, Diao L, Chatterjee P et al (2020) Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models. J Clin Investig 130:942–957

CAS  Article  Google Scholar 

Zhao Y, Adjei A (2014) The clinical development of MEK inhibitors. Nat Rev Clin Oncol 11:385–400

CAS  Article  Google Scholar 

Chelliah M, Do H, Zinn Z, Patel V, Jeng M, Khosla R, Truong M, Marqueling A, Teng J (2018) Management of complex arteriovenous malformations using a novel combination therapeutic algorithm. JAMA Dermatol 154:1316–1319

Article  Google Scholar 

Govindarajan V, Burks J, Luther E, Thompson J, Starke R (2021) Medical adjuvants in the treatment of surgically refractory arteriovenous malformations of the head and face: case report and review of literature. Cerebrovasc Dis 50:493–499

CAS  Article  Google Scholar